LEXICON PHARMACEUTICALS INC's ticker is and the CUSIP is 528872AB0. A total of 12 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $21,586,000,000 | -20.4% | 12,000,000 | 0.0% | 0.42% | +3.5% |
| Q3 2016 | $27,118,000,000 | +20.4% | 12,000,000 | 0.0% | 0.40% | -17.1% |
| Q2 2016 | $22,523,000,000 | +64.2% | 12,000,000 | +41.2% | 0.49% | +92.9% |
| Q1 2016 | $13,714,000,000 | -8.3% | 8,500,000 | 0.0% | 0.25% | 0.0% |
| Q4 2015 | $14,952,000,000 | – | 8,500,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 14,500,000 | $9,538,000 | 1.70% |
| WOLVERINE ASSET MANAGEMENT LLC | 12,250,000 | $8,113,000 | 0.10% |
| DeepCurrents Investment Group LLC | 1,000,000 | $801,000 | 0.05% |
| LAZARD ASSET MANAGEMENT LLC | 12,500,000 | $8,193,000 | 0.01% |
| Verition Fund Management LLC | 709,000 | $465,000 | 0.01% |
| Citadel Advisors | 31,800,000 | $20,177,000 | 0.01% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 10,500,000 | $7,593,600,000 | 0.01% |
| DEUTSCHE BANK AG\ | 4,500,000 | $2,882,000 | 0.00% |
| MACKAY SHIELDS LLC | 187,000 | $123,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |